Review

Adult Pancreatic Alpha-Cells: A New Source of Cells for Beta-Cell Regeneration

Cheng-Ho Chung^1,2,3, Fred Levine¹

Manuscript submitted July 9, 2010; resubmitted July 27, 2010; accepted August 9, 2010.

Keywords: stem cell, duct, pancreatic duct ligation, beta-cell, alpha-cell, conversion, insulin, glucagon, genetic lineage tracing, proliferation

Abstract

Beta-cell deficit is the major pathological feature in type 1 and type 2 diabetes patients, and plays a key role in disease progression. In principle, beta-cell regeneration can occur by replication of pre-existing beta-cells, or by beta-cell neogenesis from stem/progenitors. Unfortunately, beta-cell replication is limited by the almost complete absence of beta-cells in patients with type 1 diabetes, and the increasing recognition that the beta-cell replicative capacity declines severely with age. Therefore, beta-cell neogenesis has received increasing interest. Many different cell types within the pancreas have been suggested as potential beta-cell stem/progenitor cells, but the data have been conflicting. In some cases, this may be due to different regeneration models. On the other hand, different results have been obtained with similar regeneration models, leading to confusion about the nature and existence of beta-cell neogenesis in adult animals. Here, we review the major candidates for adult regeneration pathways, and focus on the recent discovery that alpha-cells can function as a novel beta-cell progenitor. Of note, this is a pathway that appears to be unique to beta-cell neogenesis in the adult, as the embryonic pathway of beta-cell neogenesis does not proceed through a glucagon-positive intermediate. We conclude that beta-cell neogenesis from alpha-cells is a new pathway of potential therapeutic significance, making it of high importance to elucidate the molecular events in alpha- to beta-cell conversion.

Fulltext: HTML , PDF (1.1 MB)

This article has been cited by other articles:

	IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization Li CR, Deiro MF, Godebu E, Bradley LM J Autoimmun 2011. 37(3):217-227
	Reprogramming gut and pancreas endocrine cells to treat diabetes Tuduri E, Kieffer TJ Diabetes Obes Metab 2011. 13(Suppl 1):53-59
	Beta-cell generation: can rodent studies be translated to humans? Carlotti F, Zaldumbide A, Ellenbroek JH, Spijker HS, Hoeben RC, de Koning EJ J Transplant 2011. 2011:892453
	The quest for tissue stem cells in the pancreas and other organs, and their application in beta-cell replacement Houbracken I, Bouwens L Rev Diabet Stud 2010. 7(2):112-123